MinuteClinic inks deal with American CareSource
MinuteClinic’s partnership with ancillary care network services company American CareSource not only underscores the fact that the medical community is embracing the clinic model and encouraging use, but it also aims to help reduce healthcare insurance expenses for ACS members at a time when healthcare costs and reform are top of mind.
According to David Boone, CEO of ACS, a primary objective of the company is to provide clients, and ultimately the consumer, with more cost effective and convenient alternatives to hospital- and physician office-based services. Obviously, ACS understands the importance and value of the convenient care industry given that it selected CVS Caremark’s MinuteClinic business to help it meet that goal.
As previously reported by Drug Store News, a 2008 HealthPartners study found that care delivered in such retail-based medical clinics as MinuteClinic are between 32% and 35% less, compared with care delivered in physician offices and urgent care locations. That study which was one of the first to analyze cost and care in retail clinics, examined five of the most common conditions seen in MinuteClinics: sore throat, ear infections, sinus infections, pink eye and bladder and kidney infections.
Meanwhile, for the convenient care industry, news of the partnership between MinuteClinic and ACS is yet one more nod to the fact that the medical community is embracing the retail-based clinic model and understands the quality, affordable care that these clinics offer patients.
Diagnostic Devices in contract with two states for Medicaid-covered blood glucose monitoring systems
CHARLOTTE, N.C. Diagnostic Devices on Wednesday announced contracts with the states of Illinois and Missouri around Medicaid coverage of its Prodigy line of blood glucose monitoring systems and test strips.
“We will continue working with other states for coverage under their Medicaid programs, and to demonstrate to them the savings Illinois and Missouri taxpayers will realize with the Prodigy family of products,” stated Rick Admani Abulhaj, Diagnostic COO.
A recent study by University of Florida PharmD candidates found the “talking” feature of the Prodigy AutoCode meter made a “significant improvement” in overall diabetes control and compliance among patients who took part, the company noted.
The Prodigy Voice meter for blind or low-vision diabetes patients has been honored with awards from both the National Federation of the Blind and the American Foundation for the Blind, the company added.
Fairhaven Health presents clinical study results for FertilAid for Men
BELLINGHAM, Wash. Fairhaven Health, which manufactures a male fertility supplement, recently presented a clinical study at the American Society of Andrology’s annual meeting, the company announced Tuesday.
Results from a recent clinical study indicate that FertilAid for Men provides significant improvements in sperm quality for men with abnormal sperm parameters. In particular, results of the 90-day, double blind, placebo-controlled study suggest that FertilAid for Men supports significant increases in the total number of normal motile sperm. Previous clinical studies have suggested a strong relationship between the “total normal-motile sperm count” and the fertility of the man.
“Most of the men that had increased sperm counts while taking FertilAid for Men also showed improvements of 20% or more in the number of healthy sperm,” stated lead researcher J. Ellington.
FertilAid for Men is a male fertility supplement that integrates vitamins, antioxidants, a proprietary blend of herbal ingredients and the amino acid, l-carnitine. Scientific literature suggests that antioxidants can improve male fertility by reducing oxidative stress and damage to spermatozoa, while supporting fundamental protective functions of the seminal plasma which insulate and nourish sperm. In independent studies, antioxidants reduce “free-radical” damage, in particular to the sperm’s DNA or genetic material, resulting in better pregnancy outcomes.
Research on the amino acid, l-carnitine, yields similar pro-fertility findings: L-carnitine supports “sperm metabolism”, or the ability for sperm to break down complex molecules to produce energy. L-carnitine has been shown in a number of clinical studies to enhance several fundamental sperm parameters, including sperm concentration, motility and normal morphology.
Fairhaven Health’s distribution partners include drugstore.com, BabyCenter and CVS.com, as well as a number of clinics and private practices nationwide.